Ricken (Liquan) Ma

Ricken provides clinical and regulatory expertise to optimize product development programs innovatively and strategically and interactions with regulatory agencies, also helps clients by performing gap analysis of their drug clinical processes, providing regulatory solutions to address specific client needs and troubleshooting potential issues.

Work experience

Prior to joining Parexel, Ricken had over 10 years of clinical medicine and drug development experience that includes senior clinical reviewer at China HA, R&D experience in MNC pharma company, and hospital clinical practice.

His R&D experience included professional (clinical & regulatory) advices on product pipeline and CDP of specific cases, as well as marketing authorization strategy in China.

Ricken has worked as senior clinical reviewer at China CDE/NMPA, responsible for different therapeutic areas and indications (e.g., dermatology, ophthalmology), assessing INDs, NDAs, ANDAs, BLAs and supplementary applications after licencing for hundreds of innovative drugs and generics.

Education

Ricken received his MD in Internal Medicine (Cardiovascular) from Beijing Tiantan Hospital, China and his master’s degree of Pathophysiology from Capital Medical University, Beijing, China.